HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 25, 1999, Pages 14228-14233

  Hanus L ^a   Breuer, A ^a   Tchilibon, S ^a   Shiloah, S ^a   Goldenberg, D ^a   Horowitz, M ^b   Pertwee, R G ^c   Ross, R A ^c   Mechoulam, R ^a   Fride, E ^a,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ARIEL UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; ARACHIDONIC ACID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; FORSKOLIN; PIVALIC ACID; RESORCINOL; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CHO CELL; CONTROLLED STUDY; DEFECATION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; GENETIC TRANSFECTION; HYPERTENSION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; ARACHIDONIC ACID; BLOOD PRESSURE; BORNANES; CANNABINOIDS; CYCLIC AMP; FEMALE; MICE; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 12944263838     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.25.14228     Document Type: Article

References (44)

1. Mechoulam, R. (1986) in Cannabinoids as Therapeutic Agents, ed., Mechoulam, R. (CRC, Boca Raton, FL), pp. 1-19.
2. Gaoni, Y. & Mechoulam, R. (1964) J. Am. Chem. Soc. 86, 1646.
3. Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Science 258, 1946-1949.
4. Mechoulam, R., Ben-Shabat, S., Hanuš, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) Biochem. Pharmacol. 50, 83-90.
5. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K. Yamashita, A. & Waku, K. (1995) Biochem. Biophys. Res. Commun. 215, 89-97.
6. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R. & Rice, K. C. (1990) Proc. Natl. Acad. Sci. USA 87, 1932-1936.
7. Howlett, A. C. (1998) Neurobiol. Dis. 5, 405-416.
8. Munro, S., Thomas, K. L. & Abu-Shaar, M. (1993) Nature (London) 365, 61-65.
9. Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. & Pertwee, R. G. (1997) Eur. J. Pharmacol. 339, 53-61.
10. Pertwee, R. G. (1999) Life Sci. 65, 597-605.
11. Axelrod, J. & Felder, C. C. (1998) Neurochem. Res. 23, 575-581.
12. Pertwee, R. G. (1997) Pharmacol. Ther. 74, 129-180.
13. Breivogel, C. S. & Childers, S. R. (1998) Neurobiol. Dis. 5, 417-431.
14. Mechoulam, R., Fride, E. & Di Marzo, V. (1998) Eur. J. Pharmacol. 359, 1-18.
15. Mechoulam, R., Lander, N., Breuer, A. & Zahalḱa, J. (1990) Tetrahedron: Asymmetry 1, 315-319.
16. Martin, B. R., Compton, D. R., Thomas, B. F., Prescott, W. R., Little, P. J., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R. & Ward, S. J. (1991) Pharmacol. Biochem. Behav. 40, 471-478.
17. Fride, E. & Mechoulam, R. (1993) Eur. J. Pharmacol. 231, 313-314.
18. Devane, W. A., Breuer, A., Sheskin, T., Jarbe, T. U. C., Eisen, M. & Mechoulam, R. (1992) J. Med. Chem. 35, 2065-2069.
19. Ross, R. A., Gibson, T. M., Stevenson, L. A., Saha, B., Crocker, P., Razdan, R. K. & Pertwee, R. G. (1999) Br. J. Pharmacol., 128, 735-743.
20. Young, J. M., Spires, D. A., Bedord, C. J., Wagner, B., Ballaron, S. J. & De Young, L. M. (1984) J. Invest. Dermatol. 82, 367-371.
21. Tjolson, A., Berge, O. G., Hunskaar, S., Rosland, J. H. & Hole, K. (1992) Pain 51, 5-17.
22. Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. (1998) Nature (London) 394, 277-281.
23. Jaggar, S. I., Hasnie, F. S., Sellaturay, S. & Rice, A. S. C. (1998) Pain 76, 189-199.
24. Barth, F. (1998) Exp. Opin. Ther. Patents 8, 301-313.
25. Gareau, Y., Dufresne, C., Gallant, M., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N., Weech, P. K., Metters, K. M. & Labelle, M. (1996) Bioorgan. Med. Chem. Lett. 6, 189-194.
26. Huffman, J. W., Yu, S., Showalter, V., Abood, M. E., Wiley, J. L., Compton, D. R., Martin, B. R., Bramblett, R. D. & Reggio, P. H. (1996) J. Med. Chem. 39, 3875-3877.
27. Gallant, M., Dufresne, C., Gareau, Y., Guay, D., Leblanc, Y., Prasit, P., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N., et al. (1996) Biorg. Med. Chem. Lett. 6, 2263-2268.
28. Ross, R. A., Brockie, H. C, Stevenson, L. A., Murphy, V. L., Templeton, F., Makriyannis, A. & Pertwee, R. G. (1999) Br. J. Pharmacol. 126, 665-672.
29. Mechoulam, R., Devane, W. A. & Glaser, R. (1992) in Marijuana/ Cannabinoids: Neurobiology and Neurophysiology, eds. Murphy, L. & Bartke, A. (CRC, Boca Raton, FL), pp. 1-33.
30. Shook, J. E. & Burks, T. F. (1989)J. Pharmacol. Exp. Ther. 249, 444-449.
31. Krowicki, Z. K., Moerschbaecher, J. M., Winsauer, P. J., Digavalli, S. V. & Hornby, P. J. (1999) Eur. J. Pharmacol. 371, 187-196.
32. Fride, E. (1995) Brain Res. 697, 83-90.
33. Calignano, A., La Rana, G., Makriyannis, A., Lin, S. Y., Beltramo, M. & Piomelli, D. (1997) Eur. J. Pharmacol. 340, R7-R8.
34. Wagner, J. A., Varga, K. & Kunos, G. (1998) J. Mol. Med. 76, 824-836.
35. Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R. & Kunos, G. (1997) Nature (London) 390, 518-521.
36. Varga, K., Wagner, J. A., Bridgen, D. T. & Kunos, G. (1998) FASEB J. 12, 1035-1044.
37. Wagner, J. A., Varga, K., Jarai, Z. & Kunos, G. (1999) Hypertension 33 (Part II), 429-434.
38. Mechoulam, R., Fride, E., Ben-Shabat, S., Meiri, U. & Horowitz, M. (1998) Eur. J. Pharmacol. 362, R1-R3.
39. Nakamura-Palacios, E. M., Moerschbaecher, J. M. & Barker, L. A. (1999) CNS Drug Rev. 5, 43-58.
40. Showalter, V. M., Compton, D. R., Martin, B. R. & Abood, M. E. (1996) J. Pharmacol. Exp. Ther. 278, 989-999.
41. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Bohme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) Science 283, 401-404.
42. Lake, K. D., Compton, D. R., Varga, K., Martin, B. R. & Kunos, G. (1997) J. Pharmacol. Exp. Ther. 281, 1030-1037.
43. Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. & Bonner, T. I. (1999) Proc. Natl. Acad. Sci. USA 96, 5780-5785.
44. Ankier, S. I. (1974) Eur. J. Pharmacol. 27, 1-4.